Stockhead on MSN
Health check: Syntara goes to the well for $10 million to fund advanced cancer trial
Myelofibrosis drug developer Syntara has gone to the well for $10m, the latest biotech to tap the market in a ... Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results